Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus

about

Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus

Item

http://www.wikidata.org/entity/Q36785475

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Effects of bromocriptine mesyl ...... with type-2 diabetes mellitus

@en

type

Item

label

Effects of bromocriptine mesyl ...... with type-2 diabetes mellitus

@en

prefLabel

Effects of bromocriptine mesyl ...... with type-2 diabetes mellitus

@en

P1476

Effects of bromocriptine mesyl ...... with type-2 diabetes mellitus

@en

P2093

Farhad Niafar

http://www.w3.org/2001/XMLSchema#string

Kavus Shahsavarinia

http://www.w3.org/2001/XMLSchema#string

Leili Pourafkari

http://www.w3.org/2001/XMLSchema#string

Mitra Niafar

http://www.w3.org/2001/XMLSchema#string

Nushin Milanchian

http://www.w3.org/2001/XMLSchema#string

P2860

Relationship between homocysteine level and diabetic retinopathy: a systematic review and meta-analysis

High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus

Homocysteine lowering with folic acid and B vitamins in vascular disease

Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis.

Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes.

Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes.

High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone

The importance of hyperhomocysteinemia as a risk factor for diseases: an overview.

Efficacy and Safety of Bromocriptine-QR in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

P304

8-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15171/JCVTR.2016.02

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nader D. Nader

P577

2016-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299340974

http://www.w3.org/2001/XMLSchema#string

P698

27069561

http://www.w3.org/2001/XMLSchema#string

P932

4827141

http://www.w3.org/2001/XMLSchema#string